← All stocks

Pelthos Therapeutics Inc.

PTHS No buying or selling
CIK 0001919246 #4321 in the set updated 18 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

8 insiders · 0 transactions

There is no salary here to measure against. Pelthos Therapeutics Inc.'s chief executive is paid a token, so dividing a holding by it says nothing.

Which is why this company is in neither direction of the chief executive filter on the transactions page. A stake that cannot be expressed as a multiple is not the same thing as a small one.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Davis Todd C
Director
1,575,834
$42.98M
+3,851%
LIGAND PHARMACEUTICALS INC entity
Director
1,500,000
$40.91M
Friedberg Ezra M
Director
111,042
$3.03M
+160.8%
Francis Knuettel II
CFO, Treas & Secty
30,841
$841.14K
−15.0%
Malamut Richard
Director
27,422
$747.89K
−2.1%
Greenleaf Peter
Director
23,884
$651.40K
−6.3%
Pauls Matthew
Director
14,364
$391.75K
−3.4%
Einhorn Andrew J.
Director
12,000
$327.28K

No percentages here. This company's share count has moved by a factor of 2.0 over the window, from 3,042,143 to 6,103,813 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 23 Feb 2024